Highlights of The Neurotechnology Industry 2005

• The three sectors of the neurotechnology industry are revealed:  neuropharmaceuticals with revenues of $87 billion and 13% growth annually; neurodevices with revenues of $2.8 billion and 20% growth annually; and neurodiagnostics with revenues of $12 billion and 11% growth annually
• Up-to-date market data and detailed competitive intelligence for over 15 major markets including Alzheimer's, Parkinson's, pain, ADHD, sleep disorders, sensory disorders, depression, anxiety, pain, and addiction
• Compounds and devices in clinical trials by company, mechanism of action, and stage of development
• Profiles of 350 public & private neurotech including neuropharmaceutical, neurodevice, neurodiagnostic companies
• Worldwide government research, private funding and public investment trends
• Analysis of the 10 most active neurotech venture capital firms, including investments by market segment
• Public neurotech investment trends, including a neurotech tracking index highlighting 30 public neurotech companies
• Extensive discussion of the specific technological, demographic, regulatory, and IP trends driving neurotech
• And much more...(see table of contents)